PI3K activation and lack of PTEN Signaling activation in the Stages IIIC and IV Group, compared to each of the other groups, is concordant with a loss of PTEN repression of PI3K as endometrial cancer cells undergo EMT and metastasize. The gene discussed is PTEN; the disease is endometrial cancer.